期刊文献+

法舒地尔对心力衰竭大鼠心室重塑干预与Rho GTPases活性的作用 被引量:8

Effects of fasudil on ventricular remodeling and Rho GTPases activity in rats with heart failure
下载PDF
导出
摘要 目的:以升主动脉缩窄压力超负荷心力衰竭大鼠为研究对象,观察Rho激酶抑制剂法舒地尔对心室重塑和心肌组织Rho家族的小分子鸟苷酸三磷酸酶(Rho GTPases)活性的影响,并探讨两者之间的关系。方法:将雌性心力衰竭Wistar大鼠随机分2组(n=10),法舒地尔(5 mg·kg^(-1))组和模型组,同时制备假手术组;模型组、假手术组用等量生理盐水每日2次腹腔注射。测定治疗4 wk后组织Rho GTPases活性。结果:法舒地尔组左室重量-体重比明显下降(P<0.01),心室重构减轻,心肌组织Rho GTPases活性降低(P<0.01)。结论:Rho激酶抑制剂法舒地尔抑制左室重塑与心肌组织Rho GTPases活性有关。 AIM: To study the relationship between ventricular remodeling and tissue Rho GTPases activity based on observing the effects of Rho kinase inhibitor fasudil in cardiac tissue of pressure overload heart failure model rats. METHODS: Twenty female Wistar rats with heart failure were divided randomly into 2 groups in = 10) : fasudil group (fasudil 5 mg·kg^-1, bid, ip) and model group (sodium chloride 0.1 mL, bid, ip) . Ten age-matched rats received sham operation were as sham-operation group (sodium chloride 0.1 mL, bid, ip) . After 4-week treatment, Rho GTPases activity was investigated in the three groups. RESULTS: Fasudil contributed to lower the ratio of left ventricular weight to body weight and relieve ventricular remodling (P 〈 0.01 ), and Rho GTPases activity was lowered in cardiac tissue (P 〈 0.01 ) . CONCLUSION: Fasudil can inhibit tissue remodeling in left ventricle through lowering Rho GTPases activity.
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2007年第9期671-674,共4页 Chinese Journal of New Drugs and Clinical Remedies
基金 沈阳市科学技术计划项目(1063317-1-01)
关键词 蛋白质酪氨酸激酶 法舒地尔 心力衰竭 Rho家族的小分子鸟苷酸三磷酸醇活性 心室重塑 protein-tyrosine kinase fasudil heart failure Rho GTPases activity ventricular remodeling
  • 相关文献

参考文献13

  • 1LEUNG T,MANSER E,TAN L,et al.A novel serine/threonine kinase binding the Ras-related RhoA GTPase which thranslocates the kinase to peripheral[J].J Biol Chem,1995,270 (49):29051-29054. 被引量:1
  • 2SHIMOKAWA H.Rho-kinase as a novel therapeutic target in treatment of cardiovascular diseases[J].J Cardiovasc Pharmacol,2002,39(3):319-327. 被引量:1
  • 3VATNER DE,KUNZE DL.Prologue:low-molecular-weight GTPases in the heart and circulation[J].Am J Physiol Heart Circ Physiol,2000,278(6):H1733-H1735. 被引量:1
  • 4包伟珂,柏树令,王军,谷春久.升主动脉缩窄鼠模型制作及临床意义[J].中国临床解剖学杂志,1999,17(1):66-67. 被引量:28
  • 5van AELST L,D'SOUZA-SCHOREY C.Rho GTPase and signaling networks[J].Genes Dev,1997,11(18):2295-2322. 被引量:1
  • 6KJALLER L,HALL A.Signaling to Rho GTPase[J].Exp Cell Res,1999,253(1):166-179. 被引量:1
  • 7NAKAGAWA O,FUJISAWA K,ISHIZAKI T,et al.ROCK-Ⅰ and ROCK-Ⅱ,two isoforms of Rho-associted coiled-coil forming protein serine/threonine kinase in mice[J].FEBS Lett,1996,392 (2):189-193. 被引量:1
  • 8AMANO M,FUKATA Y,KAIBUCHI K,et al.Regulation and functions of Rho-associated kinase[J].Exp Cell Res,2000,261(1):44-51. 被引量:1
  • 9ISHIZAKI T,UEHATA M,TAMECHIKA I,et al.Pharmacological properties of Y27632,a specific inhibitor of Rho-associated kinases[J].Mol Pharmacol,2000,57 (5):976-983. 被引量:1
  • 10NAGUMO H,SASAKI Y,ONO Y,et al.Rho kinase inhibitor HA-1077 prevents Rho-mediated mysin phosphatase inhibitor in smooth muscle cells[J].Am J Physiol Cell Physiol,2000,278(1):C57-C65. 被引量:1

二级参考文献15

  • 1张曼,曾定尹.法舒地尔对压力负荷心力衰竭大鼠的作用[J].中国医科大学学报,2004,33(6):484-486. 被引量:4
  • 2袁志敏,吕渠霞.心力衰竭的现代观点与诊治进展[J].心血管病学进展,1994,15(3):149-153. 被引量:52
  • 3Hisaoka T, Yano M, Ohkusa T, et al. Enhancement of Rho/Rho kinase system in regulation of vascular smooth muscle contraction in tachycardia-induced heart failure. Cardiovasc Res, 2001,49: 319-329. 被引量:1
  • 4Suematsu N, Satoh S, Kinugawa S, et al. Alpha1-adrenoceptor-Gq-RhoA signaling is upregulated to increase myofibrillar Ca2+ sensitivity in failing hearts. Am J Physiol Heart Circ Physiol, 2001, 281: H637- H646. 被引量:1
  • 5Touyz RM, Fareh J, Thibault G, et al. Intracellular Ca^2+ modulation by angiotensin Ⅱ and endothelin-1 in cardiomyocytes and fibroblasts from hypertrophied hearts of spontaneously hypertensive rats. Hypertension, 1996, 28: 797-805. 被引量:1
  • 6Amano M, Ito M, Kimura K, et al. Phosphorylation and activation of myosin by Rho-associated kinase(Rho-kinase). J Biol Chem, 1996, 271: 20246-20249. 被引量:1
  • 7Solaro RJ. Myosin light chain phosphatase: a Cinderella of cellular signaling. J Circ Res, 2000, 87:173-175. 被引量:1
  • 8Shimokawa H. Rho-kinase as a novel therapeutic target in treatment of cardiovascular diseases. Cardiovasc Pharma,2002,39: 319-327. 被引量:1
  • 9Arai M, Matsui H, Periasamy M. Sarcoplasmic reticulum gene expression in cardiac hypertrophy and heart failure. J Circ Res, 1994, 74: 555-564. 被引量:1
  • 10SOMLYO AP ,SOMLYO AV. Signal transduction by G-protein rhokinase and protein phosphatase to smooth muscle and non-muscle myosin Ⅱ [J]. J Physiol, 2000,522 Pt 2: 177-185. 被引量:1

共引文献83

同被引文献100

引证文献8

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部